These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


672 related items for PubMed ID: 6359226

  • 21. Patient with diffuse mesangial and endocapillary proliferative glomerulonephritis with hypocomplementemia and elevated anti-streptolysin O treated with prednisolone, angiotensin-converting enzyme inhibitor, and angiotensin II receptor antagonist.
    Ito S, Kuriyama H, Iino N, Iguchi S, Shimada H, Ueno M, Narita I, Nakano M, Nishi S, Karasawa R, Gejyo F.
    Clin Exp Nephrol; 2003 Dec; 7(4):290-5. PubMed ID: 14712359
    [Abstract] [Full Text] [Related]

  • 22. Predictors of one year outcome in lupus nephritis: the importance of renal biopsy.
    Esdaile JM, Federgreen W, Quintal H, Suissa S, Hayslett JP, Kashgarian M.
    Q J Med; 1991 Nov; 81(295):907-18. PubMed ID: 1808631
    [Abstract] [Full Text] [Related]

  • 23. [Lupus nephritis--clinical and morfological correlation].
    Banković N, Blagojević R, Jovanović D, Sindjić M, Pavlović S, Stojković D, Djukanović Lj.
    Srp Arh Celok Lek; 1994 Nov; 122(7-8):215-7. PubMed ID: 17974390
    [Abstract] [Full Text] [Related]

  • 24. Nephrotic syndrome in procainamide induced lupus nephritis.
    Zech P, Colon S, Labeeuw M, Bernheim J, Blanc-Brunat N.
    Clin Nephrol; 1979 Apr; 11(4):218-21. PubMed ID: 455820
    [Abstract] [Full Text] [Related]

  • 25. Significance of cytoplasmic microtubules in lupus nephritis.
    Garancis JC, Komorowski RA, Bernhard GC, Straumfjord JV.
    Am J Pathol; 1971 Jul; 64(1):1-12. PubMed ID: 4326633
    [Abstract] [Full Text] [Related]

  • 26. Prolonged membranous lupus nephritis with change of anti-ssDNA antibody titer and repeated renal relapse.
    Yumura W, Suganuma S, Nitta K, Sano Y, Uchida K, Nihei H.
    Clin Exp Nephrol; 2004 Dec; 8(4):363-8. PubMed ID: 15619038
    [Abstract] [Full Text] [Related]

  • 27. Diffuse proliferative lupus glomerulonephritis. Determination of prognostic significance of clinical, laboratory and pathologic factors.
    Magil AB, Ballon HS, Chan V, Lirenman DS, Rae A, Sutton RA.
    Medicine (Baltimore); 1984 Jul; 63(4):210-20. PubMed ID: 6377004
    [Abstract] [Full Text] [Related]

  • 28. Lupus nephritis. Electron-dense and immunofluorescent deposits and their correlation with proteinuria and renal function.
    Ben-Bassat M, Rosenfeld J, Joshua H, Hazaz B, Gura V.
    Am J Clin Pathol; 1979 Aug; 72(2):186-93. PubMed ID: 382826
    [Abstract] [Full Text] [Related]

  • 29. Predominant tubulointerstitial nephritis in a patient with systemic lupus nephritis.
    Mori Y, Kishimoto N, Yamahara H, Kijima Y, Nose A, Uchiyama-Tanaka Y, Fukui M, Kitamura T, Tokoro T, Masaki H, Nagata T, Umeda Y, Nishikawa M, Iwasaka T.
    Clin Exp Nephrol; 2005 Mar; 9(1):79-84. PubMed ID: 15830279
    [Abstract] [Full Text] [Related]

  • 30. Comparison of idiopathic and systemic lupus erythematosus-associated membranous glomerulonephropathy in children. The Southwest Pediatric Nephrology Study Group.
    Am J Kidney Dis; 1986 Feb; 7(2):115-24. PubMed ID: 3484901
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Lupus nephritis: clinical and pathological correlation.
    Leaker B, Fairley KF, Dowling J, Kincaid-Smith P.
    Q J Med; 1987 Feb; 62(238):163-79. PubMed ID: 3659257
    [Abstract] [Full Text] [Related]

  • 33. High prevalence of anti-C1q antibodies in biopsy-proven active lupus nephritis.
    Trendelenburg M, Lopez-Trascasa M, Potlukova E, Moll S, Regenass S, Frémeaux-Bacchi V, Martinez-Ara J, Jancova E, Picazo ML, Honsova E, Tesar V, Sadallah S, Schifferli J.
    Nephrol Dial Transplant; 2006 Nov; 21(11):3115-21. PubMed ID: 16877491
    [Abstract] [Full Text] [Related]

  • 34. The prognosis of biopsy-proven lupus nephritis in chinese patients: long term follow-up of 86 cases.
    Shen K, Yu Y, Tang Z, Liu Z, Li L.
    Chin Med J (Engl); 1997 Jul; 110(7):502-7. PubMed ID: 9594205
    [Abstract] [Full Text] [Related]

  • 35. Late onset systemic lupus erythematosus and lupus-like disease in patients with apparent idiopathic glomerulonephritis.
    Adu D, Williams DG, Taube D, Vilches AR, Turner DR, Cameron JS, Ogg CS.
    Q J Med; 1983 Jul; 52(208):471-87. PubMed ID: 6606818
    [Abstract] [Full Text] [Related]

  • 36. Pauci-immune lupus nephritis: a case report.
    Li FC, Hwang DY, Hung CC, Chen HC.
    Kaohsiung J Med Sci; 2008 Oct; 24(10):531-5. PubMed ID: 19181584
    [Abstract] [Full Text] [Related]

  • 37. Microalbuminuria and renal morphology in the evaluation of subclinical lupus nephritis.
    Valente de Almeida R, Rocha de Carvalho JG, de Azevedo VF, Mulinari RA, Ioshhi SO, da Rosa Utiyama S, Nisihara R.
    Clin Nephrol; 1999 Oct; 52(4):218-29. PubMed ID: 10543324
    [Abstract] [Full Text] [Related]

  • 38. Clinically occult diffuse proliferative lupus nephritis. An age-related phenomenon.
    Eiser AR, Katz SM, Swartz C.
    Arch Intern Med; 1979 Sep; 139(9):1022-5. PubMed ID: 475519
    [Abstract] [Full Text] [Related]

  • 39. Recurrence of SLE in transplanted kidneys: a follow-up transplant biopsy study.
    Nyberg G, Blohmé I, Persson H, Olausson M, Svalander C.
    Nephrol Dial Transplant; 1992 Sep; 7(11):1116-23. PubMed ID: 1336139
    [Abstract] [Full Text] [Related]

  • 40. Pathogenetic features of severe segmental lupus nephritis.
    Behara VY, Whittier WL, Korbet SM, Schwartz MM, Martens M, Lewis EJ.
    Nephrol Dial Transplant; 2010 Jan; 25(1):153-9. PubMed ID: 19703837
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 34.